CoChat

The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men

Open access
Snyder, Peter J, Ellenberg, Susan S, Cunningham, Glenn R, Matsumoto, Alvin M, Bhasin, Shalender, Barrett-Connor, Elizabeth, Gill, Thomas M, Farrar, John T, Cella, David, Rosen, Raymond C, Resnick, Susan M, Swerdloff, Ronald S, Cauley, Jane A, Cifelli, Denise, Fluharty, Laura, Pahor, Marco, Ensrud, Kristine E, Lewis, Cora E, Molitch, Mark E, Crandall, Jill P, Wang, Christina, Budoff, Matthew J, Wenger, Nanette K, Mohler, Emile R, Bild, Diane E, Cook, Nakela L, Keaveny, Tony M, Kopperdahl, David L, Lee, David, Schwartz, Ann V, Storer, Thomas W, Ershler, William B, Roy, Cindy N, Raffel, Leslie J, Romashkan, Sergei, Hadley, Evan · 2014 · Clinical Trials
Cited by 114

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Background: The prevalence of low testosterone levels in men increases with age, as does the prevalence of decreased mobility, sexual function, self-perceived vitality, cognitive abilities, bone mineral density, and glucose tolerance, and of increased anemia and coronary artery disease. Similar changes occur in men who have low serum testosterone concentrations due to known pituitary or testicular disease, and testosterone treatment improves the abnormalities. Prior studies of the effect of testosterone treatment in elderly men, however, have produced equivocal results. Purpose: To describe a coordinated set of clinical trials designed to avoid the pitfalls of prior studies and to determine definitively whether testosterone treatment of elderly men with low testosterone is efficacious in improving symptoms and objective measures of age-associated conditions. Methods: We present the scientific and clinical rationale for the decisions made in the design of this set of trials. Results: We designed The Testosterone Trials as a coordinated set of seven trials to determine if testosterone treatment of elderly men with low serum testosterone concentrations and symptoms and objective evidence of impaired mobility and/or diminished libido and/or reduced vitality would be efficacious in improving mobility (Physical Function Trial), sexual function (Sexual Function Trial), fatigue (Vitality Trial), cognitive function (Cognitive Function Trial), hemoglobin (Anemia Trial), bone density (Bone Trial), and coronary artery plaque volume (Cardiovascular Trial). The scientific advantages of this coordination were common eligibility criteria, common approaches to treatment and monitoring, and the ability to pool safety data. The logistical advantages were a single steering committee, data coordinating center and data and safety monitoring board, the same clinical trial sites, and the possibility of men participating in multiple trials. The major consideration in participant selection was setting the eligibility criterion for serum testosterone low enough to ensure that the men were unequivocally testosterone deficient, but not so low as to preclude sufficient enrollment or eventual generalizability of the results. The major considerations in choosing primary outcomes for each trial were identifying those of the highest clinical importance and identifying the minimum clinically important differences between treatment arms for sample size estimation. Potential limitations: Setting the serum testosterone concentration sufficiently low to ensure that most men would be unequivocally testosterone deficient, as well as many other entry criteria, resulted in screening approximately 30 men in person to randomize one participant. Conclusion: Designing The Testosterone Trials as a coordinated set of seven trials afforded many important scientific and logistical advantages but required an intensive recruitment and screening effort.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1740774514524032

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Cited by

See all 114

Metadata

Authors
Snyder, P. J., Ellenberg, S. S., Cunningham, G. R., Matsumoto, A. M., Bhasin, S., Barrett-Connor, E., Gill, T. M., Farrar, J. T., Cella, D., Rosen, R. C., Resnick, S. M., Swerdloff, R. S., Cauley, J. A., Cifelli, D., Fluharty, L., Pahor, M., Ensrud, K. E., Lewis, C. E., Molitch, M. E., Crandall, J. P., Wang, C., Budoff, M. J., Wenger, N. K., Mohler, E. R., Bild, D. E., Cook, N. L., Keaveny, T. M., Kopperdahl, D. L., Lee, D., Schwartz, A. V., Storer, T. W., Ershler, W. B., Roy, C. N., Raffel, L. J., Romashkan, S., & Hadley, E.
Venue
Clinical Trials
Published
2014-03-31
Volume
11
Issue
3
Pages
362-375
ISSN
  • 1740-7745 (ISSN-L)
  • 1740-7753
OpenAlex
W2120668644
Cited by
114
References
23
FWCI
13.64
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. https://app.cochat.ai/papers/10.1177/1740774514524032
The paper
Snyder, P. J., Ellenberg, S. S., Cunningham, G. R., Matsumoto, A. M., Bhasin, S., Barrett-Connor, E., Gill, T. M., Farrar, J. T., Cella, D., Rosen, R. C., Resnick, S. M., Swerdloff, R. S., Cauley, J. A., Cifelli, D., Fluharty, L., Pahor, M., Ensrud, K. E., Lewis, C. E., Molitch, M. E., . . . Hadley, E. (2014). The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clinical Trials. https://doi.org/10.1177/1740774514524032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.